Smith & Nephew unveils new bone screw; BD gets FDA OK for new diagnostic test;

 @FierceMedDev: Paper Dx could become even cheaper if this new research finding catches on. More | Follow @FierceMedDev

 @MarkHFierce: The U.S. breast implant market will grow modestly in the coming years, Millennium estimates, but Europe's won't. More | Follow @MarkHFierce

 @DamianFierce: Fresh off its $100M IPO, Globus Medical got FDA approval for its spinal disc implant. More | Follow @DamianFierce

> Smith & Nephew ($SNN) is rolling out a new surgical screw designed to prevent its loss during surgery. Release

> Kallo, a medical device and information company based in Ontario, Canada, has raised $2 million in equity funding from Kodiak Capital Group. Release

> BD Diagnostics ($BDX) gained FDA 510(k) clearance covering a new diagnostic test for rapid detection of the respiratory syncytial virus, which can cause pneumonia. Release

> VisionQuest in New Mexico is developing an imaging device that can identify medical problems through an eye screening. Story

> Israel's Argo Medical Technologies, maker of robotic exoskeletons, has chosen Massachusetts for its U.S. headquarters, and the company made a splashy announcement at AdvaMed 2012 alongside Gov. Deval Patrick. More

> ConforMIS has launched iTotal G2 Knee Replacement System, which the company says is the only patient-specific device on the market. News

> California startup Interventional Spine, a maker of percutaneous spinal implants, has raised $1.6 million, MedCity News reports. Item

Biotech News

 @FierceBiotech: Special report: The Top Phase III Disasters of 2012. Report | Follow @FierceBiotech

 @JohnCFierce: First "complete virtuous circle" for crowdfunding biotech model in France. Interesting idea. Hard to pull off. Release | Follow @JohnCFierce

 @RyanMFierce: Nice to see VentiRx deal with Celgene, and a win for a biotech with small virtual staff and big potential. More | Follow @RyanMFierce

> Merck pumped about promising IIb results for once-weekly diabetes drug. Article

> Sarepta shares boom on stellar DMD trial results. Story

Pharma News

@FiercePharma: Novartis drops its legal case against U.K. doc group that nixed Lucentis. The group changed policy after Novartis cut price. More | Follow @FiercePharma

> Celgene's Abraxane delivers in melanoma study. Article

> Sanofi, Bristol revamp Plavix partnership for post-patent world. Story

> Sanofi buying Genfar as it rolls across Latin America. News

Biomarkers News

> Singulex heads for $86.25M flotation. Item

> RNA profiles pinpoint the course of MS. Story

> Biomarkers boost success, cut costs in breast cancer clinical trials. Article

> Singulex heads for $86.25M flotation. More

Drug Delivery News

> Pfizer pays out on Antares drug delivery tech agreement. News

> Nanoparticles getting under your skin? Maybe not, actually. Story

> Noven ADHD patch heads into Phase II. Article

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.